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ORIGINAL ARTICLE
Meningococcal vaccine introduction in Mali through mass
campaigns and its impact on the health system
Sandra Mounier-Jack,a Helen Elizabeth Denise Burchett,a Ulla Kou Griffiths,a Mamadou Konate,b
Kassibo Sira Diarrab
The meningococcal A vaccine campaign led to major disruption of routine vaccination services and
reduced other services, notably antenatal care.
ABSTRACT
Objective: To evaluate the impact of the meningococcal A (MenA) vaccine introduction in Mali through mass
campaigns on the routine immunization program and the wider health system.
Methods: We used a mixed-methods case-study design, combining semi-structured interviews with 31 key informants, a
survey among 18 health facilities, and analysis of routine health facility data on number of routine vaccinations and
antenatal consultations before, during, and after the MenA vaccine campaign in December 2010. Survey and interview data
were collected at the national level and in 2 regions in July and August 2011, with additional interviews in January 2012.
Findings: Many health system functions were not affected—either positively or negatively—by the MenA vaccine
introduction. The majority of effects were felt on the immunization program. Benefits included strengthened
communication and social mobilization, surveillance, and provider skills. Drawbacks included the interruption of
routine vaccination services in the majority of health facilities surveyed (67%). The average daily number of children
receiving routine vaccinations was 79% to 87% lower during the 10-day campaign period than during other periods of
the month. Antenatal care consultations were also reduced during the campaign period by 10% to 15%. Key informants
argued that, with an average of 14 campaigns per year, mass campaigns would have a substantial cumulative negative
effect on routine health services. Many also argued that the MenA campaign missed potential opportunities for health
systems strengthening because integration with other health services was lacking.
Conclusion: The MenA vaccine introduction interrupted routine vaccination and other health services. When
introducing a new vaccine through a campaign, coverage of routine health services should be monitored alongside
campaign vaccine coverage to highlight where and how long services are disrupted and to mitigate risks to routine
services.
INTRODUCTION
A s countries introduce new vaccines at an ever-increasing pace, there have been concerns about
the effect on immunization programs and health
systems.1 There is limited evidence, however, on the
effects of introducing new vaccines on health systems.
A recent review found this was rarely the main focus of
studies and that research seldom focused on low-
income countries, such as Mali, where health systems
are generally weaker.2
Broader studies have shown that vertical disease
control programs can have both positive and negative
effects on the wider health system.3–7 Such findings
have led to regular calls for a more integrated approach
to implementing communicable disease programs.4,8–13
New vaccines may be introduced into the health
system through a variety of strategies. They can be
added to the routine immunization schedule (delivered
in health facilities or through routine outreach),
through targeted mass campaigns, or a combination
of both.
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Starting at the end of 2010, the meningococ-
cal A (MenA) vaccine (MenAfriVac) has been
introduced through phased mass campaigns in
the high-prevalence meningococcal belt in West
Africa.14,15 (MenAfriVac presents in a 10-dose
lyophilized vial and needs to be preserved at
temperatures between 2 C˚–8˚ C. Once open, a vial
should be used within 6 hours.) Several studies
have scrutinized vaccination campaigns, some of
them pointing to a possible disruption of routine
services.16–19
Between September 2010 and November 2011,
Mali introduced the MenA vaccine over 3 separate
campaigns. The first pilot phase occurred in 2
districts, followed by a second phase in Bamako,
Se´gou, and Koulikoro regions in December 2010.
In November 2011, the third phase covered the
remaining 6 regions. The campaigns targeted all
people 1–29 years old, and each campaign ran for
10 days, vaccinating a total of 10 million people.
Vaccination took place at health facilities and
through outreach in community settings, in both
rural and urban areas.
The Health Setting in Mali
Mali, a low-income country in West Africa, has a
population of 14.85 million (Table 1). It has a
young population, with 46% of the country’s
population under 15 years old.
Health care is delivered through community-
owned health facilities (Centres de Sante´ Commu-
nautaires, also called CSCOM). Key health care
professionals, such as head doctors and nurses,
are usually employed by the government while
other staff and operational costs are supported by
the local community. Vaccination is provided free
of charge, but user fees are charged for most
other services.
In Mali, the Expanded Programme on
Immunization (EPI) delivers 10 different anti-
gens to children under 5 years old, through a
combination of fixed immunization sessions at
health facilities, outreach services to community
sites, and campaigns. In 2011, the vaccination
coverage rate of the third dose of diphtheria-
tetanus-pertussis (DTP3) vaccine was 74%.21
Many health interventions in Mali are deliv-
ered through campaigns, rather than through
routine services. During 2010 and 2011, 28 health
campaigns were conducted, totaling 134 days
(Table 2). Twenty-one were national campaigns
and were used to deliver a range of interventions,
such as vaccinations, insecticide-treated bed
nets, deworming drugs, and nutritional supple-
ments; 6 had a regional focus; and 1 was
conducted in only 2 districts (Table 2). The
campaigns typically lasted 2–10 days, with an
average of 1 campaign every 3 weeks.
This study aimed to evaluate the impact of
introducing the MenA vaccine on the routine
immunization program and the wider health
system in Mali during the second phase of the
MenA vaccine introduction (in 3 regions). It was
part of a larger study that explored the impact of
a range of new vaccine introductions in 6 low-
and middle-income countries.23
TABLE 1. Mali Country Profile, 2012
Key Indicators Source
Population 14.85 million World Bank20
Life expectancy at birth 54 years World Bank20
Under-5 mortality rate 176/1,000 live births WHO21
Maternal mortality rate 464/100,000 live births Ministry of Health (Mali)22
Fertility rate 6.6 children/woman Ministry of Health (Mali)22
Population living in rural areas 70% Ministry of Health (Mali)22
DTP3 coverage rate (national) 74% WHO21
GNI per capita US$660 World Bank20
Abbreviations: DTP3, 3rd dose of diphtheria-tetanus-pertussis vaccine; GNI, gross national income; WHO, World Health Organization.
Between 2010
and 2011, Mali
vaccinated
10 million people
with the
meningococcal A
vaccine through
3 campaigns.
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TABLE 2. Public Health Campaigns in Mali, 2010–2011
Campaign Geographic Focusa Dates
2010
Polio NID (Sikasso region), 1st round 1 Region Mar 6–9
Polio NID (Sikasso region), 2nd round 1 Region Mar 26–28
Polio NID, 1st round National Apr 24–27
Polio NID, 1st round National May 28–31
NTDs (distribution of ivermectin and albendazole) National Jun 14–16
NTDs (distribution of praziquantel and azithromycin) National Jun 18–20
Polio NID, 2nd round National Jun 25–28
MILDA (distribution of bed nets) National Jul 17–20
Preventative campaign for severe malnutrition National Sep 16–18
MenAfriVac, 1st phase 2 Districts Sep 13–20
Polio NID, 3rd round National Oct 28–31
Polio NID, 3rd round National Nov 25–27
National Week of Nutrition (SIAN) National Dec 1–7
MenAfriVac, 2nd phase, Koulikoro, Se´gou, and Bamako regions 3 Regions Dec 14–23
2011
Measles SIA National Feb 28–Mar 6
Polio NID, 1st round National Mar 25–28
Polio NID, 2nd round National Apr 29–May 2
Polio NID, 3rd round National Jun 3–6
National Week of Nutrition (SIAN) National Jun 4–10
Polio NID, 4th round National Jun 23–26
NTDs (distribution of ivermectin and albendazole) National Jul 14–19
NTDs (distribution of praziquantel and azithromycin) National Jul 27–Aug 1
Polio NID 4 Regions Jul 29–Aug 1
Polio NID 5 Regions Aug 20–23
Polio NID, 4th round National Sep 30–Oct 3
Polio NID, 5th round National Oct 28–31
MenAfriVac, 3rd phase, other regions 6 Regions Nov 15–24
Polio NID, 6th round National Nov 26–29
Abbreviations: MILDA, moustiquaire impre´gne´e d’insecticide a` longue dure´e d’action (long-lasting insecticidal net); NID, National Immunization Days;
NTDs, neglected tropical diseases; SIA, supplementary immunization activities; SIAN, Semaine d’Intensification des Activite´s de Nutrition (Child
Nutrition Week).
Data from the Expanded Programme on Immunization (EPI) of Mali.
a Mali has 9 regions.
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METHODS
We used a mixed-methods study design, com-
bining semi-structured interviews with stake-
holders, a health facility survey, and analysis
of routine health facility data. Fieldwork
was conducted in July and August 2011, with
additional national stakeholders interviewed in
January 2012.
Data were collected at the national level and
in 2 of the 3 regions (Bamako and Koulikoro) in
which the second phase of the MenA vaccination
campaign took place. In both regions, 3 districts
were purposively selected to reflect different
ranges of vaccination coverage and profiles of
urbanization/rurality.
Conceptual Framework
Our analytical framework, developed by the World
Health Organization (WHO) ad-hoc working
group on new vaccines and health systems, was
an adapted version of the WHO Health Systems
Framework.1,24 It consisted of the same 6 ‘‘build-
ing blocks’’ from the WHO Health Systems
Framework but with the addition of vaccination-
specific elements within these (Table 3).
Stakeholder Interviews
Thirty-one stakeholders at national, regional,
and district levels were interviewed (Table 4).
Most interviewees were purposively selected
because of their involvement in the vaccine
introduction process. In addition, stakeholders
with responsibilities outside the EPI were inter-
viewed to seek their perception of the impact on
the broader health system and to explore the
extent to which they had collaborated with those
involved in the campaign. Interview questions
aimed to investigate critical aspects of each of the
TABLE 3. Framework for Assessing the Health Systems Impact of New Vaccine Introduction
Health System Building Block Examples of Vaccination-Specific Elements
Service delivery N Demand and acceptance
N Access and utilization
N Quality of care
N Delivery modalities
Health workforce N Availability and distribution of staff
N Training and capacity of staff
N Remuneration and satisfaction
N Performance and supervision
Health information system N Routine data collection and reporting
N Disease surveillance
Medical products, vaccines, and technologies N Forecasting of vaccines and injection supplies
N Procurement and stock management
N Cold chain management and waste disposal
Financing and sustainability N Affordability
N Domestic financing
N External financing
Leadership/governance N Regulatory policy
N Political commitment
N Organization, structure, reform, negotiation, stewardship
Source: WHO Ad-hoc Working Group on Impact of New Vaccines on Health Systems25
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6 building blocks that may have been affected
either positively or negatively by the new vaccine
introduction. They also aimed to understand how
various stakeholders were involved in the intro-
duction process.
Health Facility Surveys
In each district, 3 health facilities were selected
based on increasing distance from the district’s
main urban center. The aim was to survey a
variety of urban, semi-rural, and remote health
care facilities in each district. Staff from 18 health
facilities were surveyed using a researcher-
administered questionnaire (Table 4), adapted
from the Post-Introduction Evaluation (PIE)
methodology used in the vaccination field.26
Routine Health Facility Data
Routine data were collected on the number of
children vaccinated and antenatal care (ANC)
visits per day during the campaign and one month
before and after, in order to explore the continuity
of health services during the campaign.
Data Collection and Analysis
Prior to administering the interviews and facility
questionnaires, the aim of the study was
explained to participants and an information
sheet was provided. After discussing any ques-
tions or concerns, participants signed a consent
form. Where permitted, interviews were recorded
and transcribed. When they were not recorded,
notes were taken and typed up in detail after-
wards. Survey responses were recorded directly
onto the paper questionnaires. The interviews
and surveys were conducted in French.
Framework analysis was used to explore the
interview data.27 An initial coding framework
was developed based on preliminary assessment
of the transcripts and the building-blocks frame-
work. These codes were applied to all the
interview transcripts, and the data within each
code were then explored for themes and patterns.
The software Open Code was used to manage the
data.28 Survey data were entered into SPSS and
analyzed using descriptive statistics.
Ethical approval was obtained in Mali and from
the London School of Hygiene & Tropical Medicine.
FINDINGS
The surveyed facilities had between 2 and 16
staff members. In their normal practice outside
campaigns, almost all the facilities reported
having 1 or 2 routine vaccination sessions per
week, with 2 of 18 facilities holding sessions only
every 4 weeks.
TABLE 4. Number and Types of Key Informants, by Health System Level
Health System Level and Type of Respondent Data Collection Method Number
National
EPI, MOH Interview 2
Other, MOH Interview 8
Civil society and international agencies Interview 5
Academics/other domestic agencies Interview 4
Regional
Regional head doctor Interview 3
District
District head doctor and other staff involved in vaccination activities Interview 9
Facility
Health facility staff Questionnaire 18
Total 49
Abbreviations: EPI, Expanded Programme on Immunization; MOH, Ministry of Health.
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The introduction of the MenA vaccine had no
effect (either positive or negative) on many
aspects of the health system. Some aspects did
improve, however, while others suffered. The
majority of effects were felt on the EPI, rather
than on the broader health system. The findings
are presented below according to the 6 building
blocks.
Service Delivery
High Demand and Acceptance
Interviewees and health facility staff universally
reported that there was high demand for the new
vaccine. Social mobilization raised awareness
about the vaccine, and rumors were well-managed.
Because of its large reach, respondents felt that the
MenA vaccine campaign had improved awareness
of the benefits of vaccination and had increased
credibility of the EPI.
Reduced Access to and Use of Routine Services
Of the 18 surveyed health facilities, 12 had either
no record of any routine vaccination activities
during the 10-day MenA vaccine campaign or,
when records were not available, stated they had
stopped routine vaccination (Table 5). In the
Koulikoro region, only 2 of 9 health centers
(22%) provided routine vaccination services
during the campaign. Among the 6 facilities in
the 2 regions that continued routine vaccination
services, 1 facility vaccinated only 1 child while
another continued as usual only because
Me´decins sans Frontie`res (MSF) staff had
undertaken the MenA vaccine campaign inde-
pendently in the Kati District. However, even
though MSF carried out the campaign, staff from
2 of the surveyed health centers in the Kati
District were sent on supervision duties, which
affected routine activities.
Likewise, during the campaign, routine out-
reach vaccination services were discontinued in
5 facilities, while 2 facilities with infrequent
outreach services were able to accommodate or
postpone the work. (The remaining facilities did
not conduct outreach.) Many interviewees, nota-
bly at national and regional levels, stated that
routine vaccination had been maintained during
the campaign, but findings from the facility survey
and routine data showed that this was not the
case. The number of staff per health center did not
seem to affect whether vaccination services
continued, as the median number of staff did not
differ between those facilities that continued
vaccination services and those that did not.
Data collected from health facilities before,
during, and after the MenA vaccine campaign
suggest that the campaign had considerable impact
on routine vaccination activities and, to some
extent, on ANC consultations. The average daily
number of children vaccinated during routine
services was 79% lower during the 10-day cam-
paign period in December 2010 than during the
first 13 days of the month before the campaign
started, and 87% lower than during the last 8 days
of the month when the campaign was over
(Table 6). While fewer children were vaccinated
per day during the mid-period of all 3 months
(14th through 23rd), the average number was 71%
and 74% less during the campaign days than
during similar days in November and January,
respectively. Antenatal care consultations also
decreased during the campaign but not as
severely—there were 10% and 15% fewer consulta-
tions compared with the same days of the month
during November and January, respectively.
There was less impact on the delivery of other
health services, but nonetheless one-third of
facilities (6 of 18) reported a reduction in services,
and 2 facilities closed their ANC services for the
duration of the campaign. Most of the facilities
that reported a reduction in ANC and outpatient
services were situated in the Koulikoro region
where staffing levels were lower than in Bamako.
At health facility level, there is an impact [on other
activities] because these have only 2 staff in most
cases … the workload is much increased and some
activities are reduced because all the staff are
involved [in the campaign].
–District official, Koulikoro
TABLE 5. Continuity of Routine Vaccination Activities at Health
Facilities During Meningococcal A Vaccine Campaign (N518
Facilities)
Region
No. of Facilities
Discontinued Routine
Vaccination
Continued Routine
Vaccination
Bamako 5 4
Koulikoro 7a 2
Total 12 6
a In 3 of the 7 facilities, data were based on health facility staff recall because
records of routine vaccination activities were not available.
Routine clinic and
outreach services
were discontinued
during the MenA
campaign in most
facilities.
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Many interviewees noted the regular discon-
tinuation of routine services for a range of
health and immunization interventions during
the numerous campaigns that were organized
throughout the year. Some interviewees criti-
cized the frequency of campaigns; others under-
lined their negative impact on the health system.
It [the effect of the campaign on health services] is
immaterial [that is, difficult to measure] but this
is significant; it is an issue that can lead to loss of
trust in the service.
–National Ministry of Health (MOH)
Two interviewees commented that the new
vaccine improved equity, notably for specific
groups for which meningitis would pose a greater
risk, such as people affected by sickle cell anemia.
Vertical Delivery Modality
The campaign was organized similarly to other
vaccination campaigns, with a combination of
fixed posts and outreach teams. It did not involve
any co-delivery of other interventions (for
example, bed nets, deworming), nor did it
involve catch-up of defaulters for other vaccines.
Furthermore, once over, the campaign did not
lead to a deliberate change in how either the EPI
or other health services were delivered. The
majority of interviewees and some facility staff
felt that this was a missed opportunity. Some
interviewees suggested that a more integrated
approach with other services might have been
positive while others commented that the high
resulting workload would have made co-delivery
of other services impossible.
Many people come during the campaign, and this
would be a unique opportunity to do more
interpersonal communication and to raise aware-
ness on vaccination.
–District official, Bamako
We would like to use the vaccination campaign to
provide other services for children such as vitamin
A and deworming … it only happened once in
2007 during a measles campaign. We need to
provide a more integrated service and the spirit of
integration is not always shared.
–National MOH
Considering the workload, if we combined the
MenA campaign with other services, that would not
work.
–District official, Koulikoro
Health Workforce
Increased Workload
Additional staff members were called upon for
the duration of the MenA vaccination campaign,
and workload was reported to be high during the
period. Staff numbers and workload returned to
normal levels once the campaign ended. It was
mentioned that the workload impact was sub-
stantial in remote regions.
TABLE 6. Average Daily Numbera of Routine Services Before, During, and After the MenA Vaccination Campaign
Days of the Month Nov 2010 Dec 2010 Jan 2011
Average Daily No. of Children Vaccinatedb (in 15 health facilities)
1–13 82 62 62
14–23 45 13 50
24–30/31 70 99 81
Average Daily No. of ANC Consultations (in 18 health facilities)
1–13 88 91 90
14–23 63 56 66
24–30/31 90 94 121
Abbreviations: ANC, antental care; MenA, meningococcal A.
Cells in boldface pertain to the MenA vaccine campaign period (December 14–23, 2010).
a Only working days were considered in the calculation of the average daily service activity to make comparisons between months meaningful.
b Children receiving routine vaccinations.
The MenA
campaign did not
deliver other
health services to
people, nor did it
provide missed
vaccinations for
other vaccines.
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If in the North you have 3 persons, these will do
only the campaign during 10 days.
–National MOH
Enhanced Training and Capacity of Staff
National and sub-national health service managers
overwhelmingly stated that training for the MenA
vaccine introduction had enhanced provider skills,
often beyond those required for the specific
vaccine, acting as a general refresher on vaccina-
tion skills. They commented that a particular
emphasis had been placed on adverse events
following immunization (AEFI), waste manage-
ment, surveillance, and social mobilization.
This is thanks to MenAfriVac that I received a
theoretical training for the first time, although I
had been working in EPI since 2008.
–District official, Bamako
It was quite a comprehensive training … a
training like that is always useful, unlike for polio
for which we have no more training, and people
tend to do a bad job.
–Regional official, Bamako
However, a large majority of health facility
staff (15 of 18) reported that training had
focused primarily on the new vaccine, possibly
reflecting the fact that the new vaccine was a
‘‘one-off campaign’’ and was not yet introduced
into the routine schedule.
Motivated Staff
Interviewees generally felt that the introduction
of the MenA vaccine had motivated staff, because
of the expected outcome of reduced child morbid-
ity and mortality, or because the campaign was
associated with the payment of a per diem. The
per diem received ranged from 2,500 to 5,000 CFA
Francs (approximately US$5 to $10) per day.
During the campaign, staff is motivated, unlike
during the routine [service period] when there is no
financial motivation.
–District official, Bamako
Health Information Systems
All respondents reported that there were no
fundamental changes to the health information
system as a result of introducing the new
vaccine. However, a strong emphasis was placed
on AEFI surveillance during the introduction
itself, including strengthening the skills of health
workers to recognize and report AEFI and
training of laboratory staff. Despite perceived
better awareness, interviewees at the national
and regional level acknowledged that AEFIs were
still not routinely reported.
Medical Products, Vaccines, and
Technologies
Interviewees explained that in 2010, prior to the
introduction of the MenA vaccine and another
new vaccine (pneumococcal conjugate vaccine),
the cold chain was strengthened in 4 regions
(including our study regions) and 1,050 vaccine
carriers were provided to health facilities.
Overall, interviewees reported that the cold chain
capacity was sufficient to handle the MenA
vaccination campaign. They explained that this
was because routine vaccination had been dis-
continued, routine vaccine stocks were tempora-
rily relocated to alternative (regional and district)
places, and other temporary cold storage was
used.
Two of our fridges were full with the MenAfriVac
vaccines, so our routine vaccines were stored at
regional level and that was not an issue because we
did not do any routine vaccination apart from BCG
[bacille Calmette-Gue´rin] and polio birth doses.
This is similar during the measles campaign but
not for polio, as in general we do not stop routine
vaccination.
–District official, Bamako
The introduction of the MenA vaccine had no
impact on forecasting and procurement. It had
some limited positive impact on waste disposal,
with reports of several upgrades to waste
management equipment. However, one district
noted a major delay in disposing of a large
amount of injecting materials.
Financing and Sustainability
The introduction of the MenA vaccine was
mainly funded by external partners, such as the
Global Alliance for Vaccines and Immunisation
(GAVI), WHO, the United Nations Children’s
Fund (UNICEF), and the Canadian International
Development Agency (CIDA), although the
government of Mali also committed funds.
There was no indication that resources for the
new vaccine had displaced other investments,
although several interviewees noted that funding
was easier to commit for vaccination than for
many other health services.
Training for the
MenA vaccine
served as a
general refresher
on vaccination
skills for
providers.
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The total cost of the campaign amounted to
US$9.4 million, according to the EPI.29 A few
interviewees suggested that the introduction of 2
new vaccines (the MenA vaccine and the pneu-
mococcal conjugate vaccine) in 2011 could have
negatively impacted overall EPI operational costs.
A major positive effect noted by both inter-
viewees and facility staff was the expected sharp
decrease in meningococcal disease that enabled a
shift from epidemic response to prevention. This
was considered beneficial and cost-effective for
the health system.
The meningitis outbreak response in Bamako in
2009 lasted over 10 days and had to mobilize a lot
of resources and a high number of vaccinators.
–National MOH
The majority of interviewees and respondents
at facilities felt that the funds planned for the
implementation of the campaign were sufficient
to cover its costs. Only a few interviewees
commented that additional funds drawn from
the routine budget were used to pay for trans-
port, fuel, and communication costs and, in one
district, to supplement staff per diems for
implementing the campaign.
Interviewees and some facility staff reported
that the cancellation or reduction of routine
activities during the campaign had, in some cases,
caused a reduction in fee-for-service revenues.
Campaigns reduce routine activities because staff
deserts the facility. On one hand, this has an
impact on financial revenues of the facility, and on
the other hand, it benefits staff through per diem.
That is why staff do not usually complain about
campaigns.
–National MOH
Leadership and Governance
Interviewees noted that the government had
demonstrated high political commitment to the
vaccine introduction and that some aspects of
governance were strengthened. For instance,
AEFI surveillance was developed through the
activation of national and sub-national commit-
tees on AEFI. Capacities were further enhanced
through locally conducted clinical trials to assess
the safety and efficacy of the new vaccine and
participation in multicountry studies.30,31
Regulatory norms and standards were updated
in preparation for the introduction of the MenA
vaccine, including guidelines and training modules.
However, regulatory approval for MenAfriVac
was bypassed because of time pressure.
Collaboration among the National Communi-
cation Agency for Health, the Centre for Vaccine
Development, and the Ministry of Health was
established or strengthened during the prepara-
tory phases of the introduction, which was judged
to have long-term positive effects. This resulted in
the use of scientific evidence, including formative
research, for communication, which benefited the
broader EPI communication strategy and helped
to focus on aspects such as safety and preventing
rumors. Multidisciplinary teams for hospital sur-
veillance studies were also established. However,
enhanced collaboration did not occur between
departments within the Ministry of Health; there
was no involvement of other service delivery
departments in planning for the campaign and
no discussion of co-delivering other interventions
with the new vaccine.
Usually everybody remains in their own silo … for
instance, before [the MenA vaccine introduction] we
were not interested in post-marketing surveillance
… but this is key for effective communication.
–National stakeholder
I wish we would have been associated with the new
vaccine activities … the spirit of integration is not
always well-understood because each service thinks
they can achieve their results separately.
–National MOH
DISCUSSION
Our study is the first to triangulate findings
about stakeholders’ perceptions of the effect of
introducing the new MenA vaccine on health
services with routine health facility data. The
study found that many aspects of the health
system were not affected by the MenA vaccine
introduction, either positively or negatively,
while some aspects improved and others—
notably, continuity of routine services—suffered.
Positive Effects of the Vaccine Campaign
Some of the perceived positive effects of the new
vaccine introduction on the routine immuniza-
tion program included improved governance and
collaboration, communication and social mobili-
zation, surveillance, and provider skill strength-
ening (particularly those relevant to EPI, such as
AEFI surveillance and waste management). In
addition, a separate evaluation of the campaign
Collaboration
between health
agencies
improved during
the MenA
campaign but
not between
departments
within the Ministry
of Health.
Reduction of
routine services,
which usually
involve user fees,
during the MenA
campaign
sometimes
resulted in
reduced facility
revenue.
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showed high recognition of the disease, with 80%
of people in the community surveyed knowing
the disease prevented by the new vaccine.32
Furthermore, a widely perceived positive effect
was the reduction of disease and, to a lesser
extent, recognition that equity had been
improved at the population level. The MenA
vaccination also led to expectations of future
resource savings and service planning improve-
ments due to the avoidance of costly outbreak
responses and reactive vaccination campaigns.
Routine Services Reduced Due to Vaccine
Campaign
The main negative effect identified by the
interviewees was the discontinuation or sharp
reduction in routine vaccination services and, to
a lesser extent, reduction in the availability of
other health services, such as ANC, during the
10 days of the campaign. Analysis of routine
health facility data confirmed this finding. It is
worth noting that some interviewees believed
that routine vaccination continued as usual
during the campaign, but this was not con-
firmed by routine data. A recent quantitative
study carried out in South Africa found a similar
association between measles campaigns and
decreased routine immunization coverage.33
There is a risk that the MenA vaccine introduc-
tion may have had a negative effect on routine
vaccination coverage due to the disruption in
routine services.
However, some interviewees argued that a
countrywide vaccination campaign using the
new conjugate MenA vaccine would prevent
repeated, reactive epidemic outbreaks that also
interrupt routine health services. For example,
in its 2007 outbreak response, Burkina Faso
spent US$6.08 million (3% of the health care
budget) on vaccinating 4.1 million people plus
another US$3 million on meningitis case man-
agement. It is worth noting that because of
the short duration of protection provided by
the polysaccharide vaccine used during this
outbreak response, such costs would occur
regularly.34
The effects of the MenA vaccine campaign on
routine health services should be examined in
the broader context in which as many as 14
vaccination campaigns occur each year. Although
the effect of an individual campaign might seem
limited in the short term, the impact of multiple
campaigns is cumulative. In fact, interviewees
stressed that the high frequency of campaigns
had an adverse effect on the availability and
credibility of routine health services. Previous
studies have described drawbacks and benefits of
mass vaccination campaigns,18,35,36 and they
have pointed out that countries with weaker
health systems are more likely to experience
adverse effects of campaigns, such as disruptions
to health services.17,37,38
In line with a recent study, we found there
was a tension between the personal financial
benefit (per diems) received by staff during the
campaign and the recognition that the campaign
may disrupt health services.39
Lack of Integration of Vaccination
Campaign With Other Services
As far as the authors are aware, no other study
has yet reported on the effects of new vaccine
introductions by mass campaign on health
systems.2 Overall, the meningococcal vaccine
introduction in Mali was implemented in a
conventional vertical manner. The introduction
did establish some valuable collaborations, but it
was generally not used as a means to strengthen
the health system. Our study provides some
evidence that the mass-campaign delivery mode
may disrupt the provision of routine services and
reduce fee-for-service revenues linked to routine
medical services, although our methodology was
not designed to answer the latter. This aspect
needs to be investigated further, particularly in
terms of the possible impact on those routine
activities traditionally financed using fee-for-
service revenues.
The MenA vaccine campaign in Mali was
successfully resourced, planned, and delivered,
and it achieved high coverage.32 Mass campaigns
are generally considered an effective means of
achieving high coverage rates.40 However, the
reach to a large target population—and to
subgroups, such as young people, that seldom
use health services—was not used to provide
other benefits or services to this population,
particularly in more remote regions where con-
tact with health services is rare. We found that
this was likely to be caused by insufficient
coordination between departments within the
Ministry of Health and because of earmarked
funding for the vaccination campaign.
The lack of consideration of a more integrated
approach and the lack of involvement of other
partners in the planning process were seen by
some as a missed opportunity. Strong tension
remains between the ambition to achieve expected
The impact of
multiple
vaccination
campaigns each
year on routine
health service
delivery can add
up.
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coverage in order to prevent epidemic outbreaks
and the opportunity to use the campaign to bring
other services to the population, such as health
promotion or nutrition. Both perspectives were
cited by respondents in our study. Delivering other
interventions during the MenA vaccine campaign
would have involved important challenges (such
as logistical, financial, and communication), as
other researchers have also noted.41–43 However,
the overall lack of discussion at the level of the
Ministry of Health for such activities meant that
the campaign remained very vertical. Other
researchers have also noted that there are many
missed opportunities for using campaigns to
strengthen integrated service delivery.37,38,41,44
Relevance of Findings to Other Vaccine
Initiatives
The MenA vaccine introduction may be seen as
having unique features that are not typical of
either a routine vaccine introduction or a regular
supplementary immunization activity. However,
it does have broader relevance given that other
new vaccines in the next few years are likely to
follow the MenA vaccine introduction model of
starting with a catch-up campaign before intro-
ducing the vaccine into the routine schedule.
This could be the case with human papilloma-
virus (HPV), Japanese encephalitis, and measles-
mumps-rubella vaccines.
CONCLUSION
Recommendations to promote health systems
strengthening with vertical disease control activ-
ities are not new.16,19 However, as long as
financing remains vertical, with each program
setting its own specific objectives, it will be
difficult to mitigate the adverse effects of vaccine
campaigns on routine services. If countries and
international partners truly want to promote
health systems strengthening with new vaccine
introductions, they should start by measuring not
only vaccine campaign target coverage but also its
effect on the use of routine health services. This
would enable EPI staff to take stock of existing
disruptions, adapt planning, and reallocate
resources to ensure that routine services continue
to be delivered during campaigns.
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